{"id":"https://openalex.org/W4292059953","doi":"https://doi.org/10.3390/vaccines10081320","title":"Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines","display_name":"Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines","publication_year":2022,"publication_date":"2022-08-15","ids":{"openalex":"https://openalex.org/W4292059953","doi":"https://doi.org/10.3390/vaccines10081320","pmid":"https://pubmed.ncbi.nlm.nih.gov/36016208","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9414589"},"language":"en","primary_location":{"id":"doi:10.3390/vaccines10081320","doi":"https://doi.org/10.3390/vaccines10081320","is_oa":true,"landing_page_url":"https://doi.org/10.3390/vaccines10081320","pdf_url":"https://www.mdpi.com/2076-393X/10/8/1320/pdf?version=1660644781","source":{"id":"https://openalex.org/S4210226234","display_name":"Vaccines","issn_l":"2076-393X","issn":["2076-393X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccines","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/2076-393X/10/8/1320/pdf?version=1660644781","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Eleanor Bell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092722","display_name":"Office Of Health Economics","ror":"https://ror.org/00dtqsj35","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210092722"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Eleanor Bell","raw_affiliation_strings":["Office of Health Economics, London SW1E 6QT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Health Economics, London SW1E 6QT, UK","institution_ids":["https://openalex.org/I4210092722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017155931","display_name":"Simon Brassel","orcid":"https://orcid.org/0000-0001-7574-9671","observed_orcids":["https://orcid.org/0000-0001-7574-9671"]},"institutions":[{"id":"https://openalex.org/I4210092722","display_name":"Office Of Health Economics","ror":"https://ror.org/00dtqsj35","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210092722"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Simon Brassel","raw_affiliation_strings":["Office of Health Economics, London SW1E 6QT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Health Economics, London SW1E 6QT, UK","institution_ids":["https://openalex.org/I4210092722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104123341","display_name":"Edward Oliver","orcid":"https://orcid.org/0009-0000-7958-7016","observed_orcids":["https://orcid.org/0009-0000-7958-7016"]},"institutions":[{"id":"https://openalex.org/I4210092722","display_name":"Office Of Health Economics","ror":"https://ror.org/00dtqsj35","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210092722"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Edward Oliver","raw_affiliation_strings":["Office of Health Economics, London SW1E 6QT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Health Economics, London SW1E 6QT, UK","institution_ids":["https://openalex.org/I4210092722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023974765","display_name":"Hannah Schirrmacher","orcid":"https://orcid.org/0000-0002-9280-4537","observed_orcids":["https://orcid.org/0000-0002-9280-4537"]},"institutions":[{"id":"https://openalex.org/I4210092722","display_name":"Office Of Health Economics","ror":"https://ror.org/00dtqsj35","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210092722"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hannah Schirrmacher","raw_affiliation_strings":["Office of Health Economics, London SW1E 6QT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Health Economics, London SW1E 6QT, UK","institution_ids":["https://openalex.org/I4210092722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043442748","display_name":"Sofie Arnetorp","orcid":"https://orcid.org/0009-0004-7624-0091","observed_orcids":["https://orcid.org/0009-0004-7624-0091"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Sofie Arnetorp","raw_affiliation_strings":["Health Economics & Payer Evidence, BioPharmaceuticals Medical, AstraZeneca, 431 50 Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics & Payer Evidence, BioPharmaceuticals Medical, AstraZeneca, 431 50 Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Katja Berg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109524","display_name":"AstraZeneca (Australia)","ror":"https://ror.org/018nw3344","country_code":"AU","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210109524"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Katja Berg","raw_affiliation_strings":["Access Policy & Strategy, BioPharmaceuticals Business, AstraZeneca, Sydney, NSW 2113, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Access Policy & Strategy, BioPharmaceuticals Business, AstraZeneca, Sydney, NSW 2113, Australia","institution_ids":["https://openalex.org/I4210109524"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003617578","display_name":"Duncan Darroch-Thompson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Duncan Darroch-Thompson","raw_affiliation_strings":["International Market Access, Vaccines and Immune Therapies, BioPharmaceuticals Business, AstraZeneca, Shanghai 201203, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Market Access, Vaccines and Immune Therapies, BioPharmaceuticals Business, AstraZeneca, Shanghai 201203, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034381294","display_name":"Paula Pohja-Hutchison","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paula Pohja-Hutchison","raw_affiliation_strings":["Global Policy, BioPharmaceuticals Business, AstraZeneca, Cambridge CB2 0AA, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Policy, BioPharmaceuticals Business, AstraZeneca, Cambridge CB2 0AA, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012175059","display_name":"Bruce A. Mungall","orcid":"https://orcid.org/0000-0002-6772-1633","observed_orcids":["https://orcid.org/0000-0002-6772-1633"]},"institutions":[{"id":"https://openalex.org/I4210114036","display_name":"AstraZeneca (Singapore)","ror":"https://ror.org/023p4rz42","country_code":"SG","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210114036"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Bruce Mungall","raw_affiliation_strings":["Asia Area Medical Director, Vaccines and Immune Therapies, BioPharmaceuticals Business, AstraZeneca, Singapore 038986, Singapore"],"raw_orcid":"https://orcid.org/0000-0002-6772-1633","affiliations":[{"raw_affiliation_string":"Asia Area Medical Director, Vaccines and Immune Therapies, BioPharmaceuticals Business, AstraZeneca, Singapore 038986, Singapore","institution_ids":["https://openalex.org/I4210114036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047452259","display_name":"Stuart Carroll","orcid":"https://orcid.org/0000-0002-1237-0370","observed_orcids":["https://orcid.org/0000-0002-1237-0370"]},"institutions":[{"id":"https://openalex.org/I4210092722","display_name":"Office Of Health Economics","ror":"https://ror.org/00dtqsj35","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210092722"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stuart Carroll","raw_affiliation_strings":["Office of Health Economics, London SW1E 6QT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Health Economics, London SW1E 6QT, UK","institution_ids":["https://openalex.org/I4210092722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016565734","display_name":"Maarten Jacobus Postma","orcid":"https://orcid.org/0000-0002-6306-3653","observed_orcids":["https://orcid.org/0000-0002-6306-3653"]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Maarten Postma","raw_affiliation_strings":["Department of Pharmacy, Unit of PharmacoEpidemiology & PharmacoEconomics, University of Groningen, 9712 CP Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Unit of PharmacoEpidemiology & PharmacoEconomics, University of Groningen, 9712 CP Groningen, The Netherlands","institution_ids":["https://openalex.org/I169381384"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087861262","display_name":"Lotte Steuten","orcid":"https://orcid.org/0000-0002-5688-236X","observed_orcids":["https://orcid.org/0000-0002-5688-236X"]},"institutions":[{"id":"https://openalex.org/I4210092722","display_name":"Office Of Health Economics","ror":"https://ror.org/00dtqsj35","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210092722"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Lotte Steuten","raw_affiliation_strings":["Office of Health Economics, London SW1E 6QT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Health Economics, London SW1E 6QT, UK","institution_ids":["https://openalex.org/I4210092722"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5087861262"],"corresponding_institution_ids":["https://openalex.org/I4210092722"],"apc_list":{"value":2200,"currency":"CHF","value_usd":2303},"apc_paid":{"value":2200,"currency":"CHF","value_usd":2303},"fwci":3.216,"has_fulltext":true,"cited_by_count":24,"citation_normalized_percentile":{"value":0.91845829,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"10","issue":"8","first_page":"1320","last_page":"1320"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10833","display_name":"Vaccine Coverage and Hesitancy","score":0.7167999744415283,"subfield":{"id":"https://openalex.org/subfields/3306","display_name":"Health"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10833","display_name":"Vaccine Coverage and Hesitancy","score":0.7167999744415283,"subfield":{"id":"https://openalex.org/subfields/3306","display_name":"Health"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.14069999754428864,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13945","display_name":"Legal, Health, Environmental and COVID-19 Challenges","score":0.0414000004529953,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9039999842643738},{"id":"https://openalex.org/keywords/global-burden-of-disease","display_name":"global burden of disease","score":0.7850000262260437},{"id":"https://openalex.org/keywords/covid-19-vaccines","display_name":"COVID-19 vaccines","score":0.9480000138282776},{"id":"https://openalex.org/keywords/vaccine-equity","display_name":"vaccine equity","score":0.8009999990463257},{"id":"https://openalex.org/keywords/covax","display_name":"COVAX","score":0.9120000004768372},{"id":"https://openalex.org/keywords/excess-mortality","display_name":"excess mortality","score":0.722000002861023},{"id":"https://openalex.org/keywords/economic-losses","display_name":"economic losses","score":0.6119999885559082},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.49000000953674316},{"id":"https://openalex.org/keywords/vaccine-access","display_name":"vaccine access","score":0.3269999921321869},{"id":"https://openalex.org/keywords/low-income-countries","display_name":"low-income countries","score":0.6449999809265137},{"id":"https://openalex.org/keywords/gdp-growth","display_name":"GDP growth","score":0.503000020980835},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.593999981880188}],"concepts":[{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.6334518790245056},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.5062212347984314},{"id":"https://openalex.org/C114350782","wikidata":"https://www.wikidata.org/wiki/Q12638","display_name":"Gross domestic product","level":2,"score":0.4709509313106537},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.45469963550567627},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.4458011984825134},{"id":"https://openalex.org/C2776291640","wikidata":"https://www.wikidata.org/wiki/Q2912517","display_name":"Value (mathematics)","level":2,"score":0.4362793564796448},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.4307711720466614},{"id":"https://openalex.org/C188897","wikidata":"https://www.wikidata.org/wiki/Q5333508","display_name":"Economic impact analysis","level":2,"score":0.4143458902835846},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.35625922679901123},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.3180423676967621},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.199479877948761},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.12995994091033936},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C175444787","wikidata":"https://www.wikidata.org/wiki/Q39072","display_name":"Microeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.3390/vaccines10081320","doi":"https://doi.org/10.3390/vaccines10081320","is_oa":true,"landing_page_url":"https://doi.org/10.3390/vaccines10081320","pdf_url":"https://www.mdpi.com/2076-393X/10/8/1320/pdf?version=1660644781","source":{"id":"https://openalex.org/S4210226234","display_name":"Vaccines","issn_l":"2076-393X","issn":["2076-393X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccines","raw_type":"journal-article"},{"id":"pmid:36016208","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36016208","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccines","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9414589","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9414589/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccines (Basel)","raw_type":"Text"},{"id":"pmh:oai:pure.rug.nl:openaire/e8740896-ad18-4654-aa29-0338f0c78984","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/e8740896-ad18-4654-aa29-0338f0c78984","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bell, E, Brassel, S, Oliver, E, Schirrmacher, H, Arnetorp, S, Berg, K, Darroch-Thompson, D, Pohja-Hutchison, P, Mungall, B, Carroll, S, Postma, M & Steuten, L 2022, 'Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines', Vaccines, vol. 10, no. 8, 1320. https://doi.org/10.3390/vaccines10081320","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:8f3b9069b2b443eaa444c23b99b66e3c","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/8f3b9069b2b443eaa444c23b99b66e3c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Vaccines, Vol 10, Iss 8, p 1320 (2022)","raw_type":"article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/e8740896-ad18-4654-aa29-0338f0c78984","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/e8740896-ad18-4654-aa29-0338f0c78984","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Vaccines, 10(8):1320. MDPI AG","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.3390/vaccines10081320","doi":"https://doi.org/10.3390/vaccines10081320","is_oa":true,"landing_page_url":"https://doi.org/10.3390/vaccines10081320","pdf_url":"https://www.mdpi.com/2076-393X/10/8/1320/pdf?version=1660644781","source":{"id":"https://openalex.org/S4210226234","display_name":"Vaccines","issn_l":"2076-393X","issn":["2076-393X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccines","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"},{"score":0.8974000215530396,"display_name":"Reduced inequalities","id":"https://metadata.un.org/sdg/10"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4292059953.pdf","grobid_xml":"https://content.openalex.org/works/W4292059953.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W2148370712","https://openalex.org/W2150279738","https://openalex.org/W3033337069","https://openalex.org/W3040309044","https://openalex.org/W3088245496","https://openalex.org/W3125019407","https://openalex.org/W3130986213","https://openalex.org/W3131407834","https://openalex.org/W3163245008","https://openalex.org/W3168271482","https://openalex.org/W3200627491","https://openalex.org/W3206965589","https://openalex.org/W4205680343","https://openalex.org/W4206175278","https://openalex.org/W4206774592","https://openalex.org/W4220883857","https://openalex.org/W4392986387"],"related_works":["https://openalex.org/W4311332630","https://openalex.org/W7112573289","https://openalex.org/W3112088488","https://openalex.org/W4283395367","https://openalex.org/W4224312703","https://openalex.org/W3216382286","https://openalex.org/W4315796459","https://openalex.org/W4295754949","https://openalex.org/W4402333790","https://openalex.org/W4398152737"],"abstract_inverted_index":{"The":[0,180],"objectives":[1],"of":[2,11,20,31,45,87,167,195],"this":[3],"research":[4],"were":[5],"to":[6,22,79,91,94,142,149,182],"produce":[7],"a":[8],"macro-level":[9],"overview":[10],"the":[12,18,32,40,193],"global":[13],"COVID-19":[14,23,46],"burden":[15],"and":[16,36,42,51,61,173,197],"estimate":[17],"value":[19,54],"access":[21,125],"vaccines.":[24],"A":[25],"targeted":[26],"literature":[27],"review":[28],"collated":[29],"evidence":[30],"burden.":[33],"Linear":[34],"modelling":[35],"data":[37],"analysis":[38],"estimated":[39,73],"health":[41],"economic":[43,168],"effects":[44],"vaccines":[47,199],"delivered":[48],"in":[49,96,112,131,147,170,176],"2021,":[50,132],"whether":[52],"additional":[53],"could":[55],"have":[56,138],"been":[57,71,139],"achieved":[58],"with":[59],"broader":[60],"more":[62,84,134],"equitable":[63],"access.":[64],"By":[65],"1":[66],"December":[67],"2020,":[68],"there":[69],"had":[70,126],"an":[72],"17":[74],"million":[75],"excess":[76,135],"deaths":[77,136],"due":[78],"COVID-19.":[80],"Low-income":[81],"countries":[82,117,184,188],"allocated":[83],"than":[85,110],"30%":[86],"their":[88],"healthcare":[89,150],"budgets":[90],"COVID-19,":[92],"compared":[93],"8%":[95],"high-income":[97,183],"countries.":[98],"All":[99],"country":[100],"income":[101],"groups":[102],"experienced":[103],"gross":[104],"domestic":[105],"product":[106],"(GDP)":[107],"growth":[108],"lower":[109],"predicted":[111],"2020.":[113],"If":[114],"all":[115,187],"92":[116],"eligible":[118],"for":[119,160],"COVAX":[120],"Advance":[121],"Market":[122],"Committee":[123],"(AMC),":[124],"reached":[127],"40%":[128],"vaccination":[129],"coverage":[130],"120%":[133],"would":[137],"averted,":[140],"equivalent":[141],"USD":[143,153,165,174],"5":[144],"billion":[145],"(109)":[146],"savings":[148],"systems.":[151],"Every":[152],"spent":[154],"by":[155],"advanced":[156,162,171,178],"economies":[157,163,172],"on":[158],"vaccinations":[159],"less":[161,177],"averted":[164],"28":[166],"losses":[169],"29":[175],"economies.":[179],"cost":[181,194],"when":[185],"not":[186],"are":[189],"vaccinated":[190],"far":[191],"outweighs":[192],"manufacturing":[196],"distributing":[198],"globally.":[200]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-08-17T00:00:00"}